---
type: "Nootropic"
title: "Piracetam"
description: "Piracetam is a synthetic racetam used as a medicine for cortical myoclonus in certain countries. Evidence is not equivalent for dementia, stroke or cognitive enhancement in healthy people; prescribing conditions and renal function matter."
resource: "https://nootropikler.com/nootropics/piracetam"
tags: ["memory", "Focus", "Acetylcholine Synergy"]
timestamp: 2026-11-11T00:00:00Z
category: "cognitive"
source: "synthetic"
latin: "2-oxo-1-pyrrolidineacetamide"
language: "en"
---

# Piracetam

*2-oxo-1-pyrrolidineacetamide*

Piracetam is a synthetic racetam used as a medicine for cortical myoclonus in certain countries. Evidence is not equivalent for dementia, stroke or cognitive enhancement in healthy people; prescribing conditions and renal function matter.

## Quick profile

| Property | Value |
| --- | --- |
| Onset of Effect | No established timeframe |
| Dose used in research | Depends on the studied product and protocol |
| with choline | Requirement not established |

> Correction · 2026-11-11. Cognition and stroke findings and licensed product information were linked to sources. General dose and half-life fields were removed.

## What is Piracetam?

Piracetam is a synthetic racetam used as a medicine for cortical myoclonus in certain countries. Evidence is not equivalent for dementia, stroke or cognitive enhancement in healthy people; prescribing conditions and renal function matter.

## Mechanism of Effect

In the 1997 experiment, piracetam increased the fluidity of aged mouse, rat and human brain membranes in vitro.

An in vitro human-tissue measure is distinct from memory outcomes after treating patients. Learning findings in aged rats cannot be directly transferred to humans.

## Clinical Evidence

### Age-Related Cognitive Decline

The 2002 meta-analysis pooled 19 placebo-controlled trials in older people with cognitive impairment or dementia. Global clinical change ratings favored piracetam.

This global rating is distinct from specific memory tests. The abstract does not establish benefit in healthy young people. The first author was affiliated with manufacturer UCB.

### Myoclonus Epilepsy

These warnings come from the UK Nootropil product information for adult cortical myoclonus. They do not establish other cognitive indications or approval status in other countries.

### Dyslexia and Learning Disabilities

Wilsher and colleagues’ 1987 trial enrolled 225 children with dyslexia. Some reading measures improved in the 36-week placebo-controlled trial. Findings in this selected group do not establish general cognitive enhancement in healthy adults.

### Recovery After Brain Injury

The Ricci et al. (2012) Cochrane review included 3 trials and 1002 patients with acute ischemic stroke. Efficacy and safety remained inconclusive; consistent neurological recovery or established neuroprotection was not demonstrated.

## Dose information and research limits

> **Dose information and research limits:** This dose information describes research or product context; it is not a personal prescription, established safe upper limit or efficacy guarantee for healthy people. Extracts and different formulations should not be treated as equivalent milligram for milligram.

The Nootropil product information reports a plasma half-life of 5 hours in young adult men. Elimination depends on kidney function.

This duration does not establish a personal medication schedule or a constant for kidney impairment. It is not used for a general profile curve.

Controlled human trials have not established that choline supplementation is mandatory with racetams or prevents headaches.

## Safety and Side Effects

Piracetam is renally eliminated; dose adjustment is needed with impaired renal function and severe renal failure is a contraindication. Cerebral hemorrhage and Huntington chorea are contraindications. Bleeding risk, anticoagulants/antiplatelets and planned surgery require medical review. Abrupt withdrawal in myoclonus can trigger seizures.

## Is Piracetam Legal in Türkiye?

Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.


## Frequently Asked Questions

### What is Piracetam and what does it do?

Piracetam is a synthetic racetam used as a medicine for cortical myoclonus in certain countries. Evidence is not equivalent for dementia, stroke or cognitive enhancement in healthy people; prescribing conditions and renal function matter.

### How much should the dose of Piracetam be?

These warnings come from the UK Nootropil product information for adult cortical myoclonus. They do not establish other cognitive indications or approval status in other countries.

### Is Piracetam legal in Türkiye?

Sale and import status in Türkiye must be checked for the specific product. Verify supplement approval in the Ministry of Agriculture and Forestry GGBS list, and medicine authorization and conditions of use in TİTCK records. Online availability does not establish approval or unrestricted personal import; current Ministry of Trade conditions apply to postal and express shipments.

### What are the side effects of Piracetam?

Piracetam is renally eliminated; dose adjustment is needed with impaired renal function and severe renal failure is a contraindication. Cerebral hemorrhage and Huntington chorea are contraindications. Bleeding risk, anticoagulants/antiplatelets and planned surgery require medical review. Abrupt withdrawal in myoclonus can trigger seizures.

### When does Piracetam work?

No established timeframe

## Sources

- Giurgea C. (1972). [Pharmacology of integrative activity of the brain. Attempt at nootropic concept in psychopharmacology]. *Actualités pharmacologiques*, 25, 115–56. [PubMed · PMID 4541214](https://pubmed.ncbi.nlm.nih.gov/4541214/)
- Winblad, B. (2005). Piracetam: A review of pharmacological properties and clinical uses. *CNS Drug Reviews*, 11(2), 169–182. [PubMed · PMID 16007238](https://pubmed.ncbi.nlm.nih.gov/16007238/)
- Wilsher, C.R. et al. (1987). Piracetam and dyslexia: effects on reading tests. *Journal of Clinical Psychopharmacology*, 7(4), 230–237. [PubMed · PMID 3305591](https://pubmed.ncbi.nlm.nih.gov/3305591/)
- Ricci, S. et al. (2012). Piracetam for acute ischaemic stroke. *Cochrane Database of Systematic Reviews*, Issue 9. [PubMed · PMID 22972044](https://pubmed.ncbi.nlm.nih.gov/22972044/)
- Müller, W.E. et al. (1997). Effects of piracetam on membrane fluidity in the aged mouse, rat, and human brain. *Biochemical Pharmacology*, 53(2), 135–140. [PubMed · PMID 9037245](https://pubmed.ncbi.nlm.nih.gov/9037245/)
- Waegemans, T. et al. (2002). Clinical efficacy of piracetam in cognitive impairment: a meta-analysis. *Dementia and Geriatric Cognitive Disorders*, 13(4), 217–224. [PubMed · PMID 12006732](https://pubmed.ncbi.nlm.nih.gov/12006732/)
- ADVANZ Pharma. Nootropil 1200 mg film-coated tablets: Summary of Product Characteristics. https://www.medicines.org.uk/emc/product/101131/smpc [ADVANZ Pharma / electronic medicines compendium](https://www.medicines.org.uk/emc/product/101131/smpc)

## Related nootropics

- [Alpha-GPC](/okf/nootropics/alpha-gpc.md)
- [CDP-Choline](/okf/nootropics/cdp-choline.md)
- [Bacopa Monnieri](/okf/nootropics/bacopa-monnieri.md)
- [Lion's Mane](/okf/nootropics/lions-mane.md)
